Medically reviewed by Dr. Lemuel P. Byrd, Jr., D.C., FMCSA Certified Medical Examiner | Last updated: January 27, 2026
Rheumatoid arthritis (RA) doesn’t automatically disqualify you from DOT certification. The key factors are disease control, joint function, and medication compatibility. Most RA medications—including DMARDs like methotrexate and biologics like Humira—are compatible with commercial driving. Your examiner will assess whether your RA allows safe vehicle operation, focusing on hand grip, joint mobility, and overall function.
At Charlotte DOT Exam Center, our FMCSA-certified examiners have extensive experience evaluating this condition.
📞 Call 704-544-3494 | 💰 $70 flat rate | 🚶 Walk-ins welcome
Rheumatoid arthritis is an autoimmune condition that differs significantly from the wear-and-tear osteoarthritis common among drivers. RA involves immune system attacks on joint tissue, causing inflammation, pain, and potential joint damage. However, modern treatments have transformed outcomes, and many RA patients maintain excellent function.
For DOT certification, the focus is on your functional ability rather than the diagnosis. Can you grip the steering wheel firmly? Can you operate pedals smoothly? Can you perform safety functions? With well-controlled RA, the answer is often yes.
At Charlotte DOT Exam Center, we evaluate RA based on your current disease status and functional abilities. Most RA medications are DOT-compatible, and drivers with well-managed RA regularly obtain and maintain certification.
Rheumatoid arthritis is a chronic autoimmune disease causing joint inflammation, pain, swelling, and potential deformity. Unlike osteoarthritis, RA typically affects joints symmetrically and can involve systemic symptoms. Modern disease-modifying treatments have significantly improved outcomes for most patients.
Approximately 1.3 million Americans have rheumatoid arthritis, with women affected 2-3 times more often than men. With proper treatment, most RA patients maintain good function. Many work in physically demanding occupations including commercial driving.
The FMCSA physical qualification standards are found in FMCSA Physical Qualifications. According to the American College of Rheumatology – RA, rheumatoid arthritis affects many Americans, including commercial drivers.
The FMCSA evaluates rheumatoid arthritis based on functional capacity—your ability to safely operate a commercial motor vehicle. Key factors the medical examiner considers include:
For additional information, see the CDC Rheumatoid Arthritis and Arthritis Foundation – RA.
Commercial drivers with rheumatoid arthritis often have similar questions. Here are the most common questions we answer at Charlotte DOT Exam Center:
Yes, drivers with well-controlled RA can obtain CDL certification. Your examiner evaluates your functional ability to operate a commercial vehicle safely, not simply the RA diagnosis. Most drivers with RA who maintain good disease control can be certified.
Most RA medications are DOT-compatible. This includes DMARDs (methotrexate, sulfasalazine), biologics (Humira, Enbrel, Remicade), JAK inhibitors (Xeljanz), and NSAIDs. Corticosteroids like prednisone are also acceptable.
RA-related fatigue is common and can affect driving safety. Your examiner will ask about fatigue levels. Well-controlled RA typically has manageable fatigue, but severe fatigue despite treatment may require additional evaluation.
For well-controlled, mild RA, your primary care records may suffice. For moderate-to-severe RA or complex medication regimens, rheumatologist documentation supporting your ability to drive commercially is helpful.
Disease flares can temporarily affect function. If experiencing a significant flare during your DOT physical, you may need to reschedule or receive a shorter certification period until the flare resolves.
Stable, well-controlled RA typically receives standard certification periods. Active or poorly controlled disease may receive shorter certification to monitor disease status.
Some hand deformity doesn’t necessarily prevent certification if you can still grip and operate controls effectively. Your examiner will assess your actual functional ability rather than appearance.
Bring a list of all medications with dosages. For RA, listing your DMARDs, biologics, and any other treatments helps document your care. Most RA medications don’t raise DOT concerns.
Understanding which medications are compatible with commercial driving helps you prepare for your DOT physical and communicate effectively with your medical examiner.
| Medication Category | Common Examples | CDL Compatible? |
|---|---|---|
| NSAIDs | Ibuprofen, naproxen, celecoxib, meloxicam | ✅ Yes |
| Conventional DMARDs | Methotrexate, sulfasalazine, leflunomide, hydroxychloroquine | ✅ Yes |
| Biologics (TNF inhibitors) | Humira, Enbrel, Remicade, Cimzia, Simponi | ✅ Yes |
| Biologics (Other) | Orencia, Actemra, Rituxan, Kevzara | ✅ Yes |
| JAK Inhibitors | Xeljanz, Olumiant, Rinvoq | ✅ Yes |
| Corticosteroids | Prednisone, methylprednisolone | ✅ Yes |
| Corticosteroid Injections | Joint injections | ✅ Yes |
| Opioid Pain Medications | If needed for RA pain | ❌ Generally not permitted |
✅ = Compatible | ⚠️ = Requires evaluation | ❌ = Not compatible while driving
Your DOT medical certificate duration depends on your condition’s status, treatment effectiveness, and documentation provided:
| Severity Level | Characteristics | Typical Certificate | Documentation Required |
|---|---|---|---|
| Mild/Well-controlled | Minimal symptoms, good function, stable on treatment | 2 years | Medication list |
| Moderate (controlled) | Some symptoms but good function on treatment | 1-2 years | Rheumatologist records recommended |
| Moderate (active) | Ongoing symptoms affecting function | 1 year or defer | Rheumatologist documentation required |
| Severe/Poorly controlled | Significant functional impairment | Case-by-case | Specialist clearance required |
| Situation | Typical Wait | Documentation Needed |
|---|---|---|
| Disease flare | Until symptoms controlled | Rheumatologist documentation of control |
| New biologic started | After initial dosing and tolerance established (4-8 weeks) | Medication tolerance documentation |
| Joint surgery for RA | After full recovery (varies by procedure) | Surgeon clearance |
| New RA diagnosis | After treatment initiated and stable | Treatment records + functional assessment |
Proper documentation streamlines your DOT physical and supports certification. Gather these items before your appointment:
Drivers with rheumatoid arthritis may have related conditions also evaluated during the DOT physical:
For complete information, see our DOT Physical Medical Conditions hub page.
Yes, if your RA is well-controlled and you have adequate functional ability.
Yes, most RA medications including DMARDs and biologics are DOT-compatible.
Well-controlled RA should have manageable fatigue. Severe fatigue may require evaluation.
Helpful for moderate-to-severe RA; may not be needed for mild, stable disease.
You may need to reschedule or receive shorter certification until the flare resolves.
Not necessarily—functional ability matters more than appearance.
Charlotte DOT Exam Center provides expert DOT physical examinations for commercial drivers with rheumatoid arthritis. Our FMCSA-certified medical examiners—Dr. Alan M. Tebby, D.C. and Dr. Lemuel Byrd—have extensive experience with this condition.
8415 Pineville-Matthews Road, Suite 102
Charlotte, NC 28226
Questions? Call us at 704-544-3494 to discuss your rheumatoid arthritis and DOT certification requirements.